SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000849146-22-000009
Filing Date
2022-02-01
Accepted
2022-02-01 16:05:45
Documents
48
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q lfvn-20211231.htm   iXBRL 10-Q 1122706
2 EX-31.1 lfvn_123121xex311.htm EX-31.1 9737
3 EX-31.2 lfvn_123121xex312.htm EX-31.2 9717
4 EX-32.1 lfvn_123121xex321.htm EX-32.1 5043
5 EX-32.2 lfvn_123121xex322.htm EX-32.2 5023
  Complete submission text file 0000849146-22-000009.txt   4656615

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfvn-20211231.xsd EX-101.SCH 27228
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lfvn-20211231_cal.xml EX-101.CAL 55911
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lfvn-20211231_def.xml EX-101.DEF 104150
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfvn-20211231_lab.xml EX-101.LAB 420799
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfvn-20211231_pre.xml EX-101.PRE 242873
42 EXTRACTED XBRL INSTANCE DOCUMENT lfvn-20211231_htm.xml XML 673149
Mailing Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043
Business Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043 801-432-9000
Lifevantage Corp (Filer) CIK: 0000849146 (see all company filings)

IRS No.: 841097796 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35647 | Film No.: 22578933
SIC: 2834 Pharmaceutical Preparations